These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2574 related articles for article (PubMed ID: 25953784)

  • 21. Calculating statistical power in Mendelian randomization studies.
    Brion MJ; Shakhbazov K; Visscher PM
    Int J Epidemiol; 2013 Oct; 42(5):1497-501. PubMed ID: 24159078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of the instrumental inequalities in simulated mendelian randomization analyses with coarsened exposures.
    Diemer EW; Shi J; Hernan MA; Swanson SA
    Eur J Epidemiol; 2024 May; 39(5):491-499. PubMed ID: 38819552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adding Mendelian randomization to a meta-analysis-a burgeoning opportunity.
    Niu W; Gu M
    Tumour Biol; 2016 Feb; 37(2):1527-9. PubMed ID: 26695146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Applying Mendelian randomization to appraise causality in relationships between nutrition and cancer.
    Wade KH; Yarmolinsky J; Giovannucci E; Lewis SJ; Millwood IY; Munafò MR; Meddens F; Burrows K; Bell JA; Davies NM; Mariosa D; Kanerva N; Vincent EE; Smith-Byrne K; Guida F; Gunter MJ; Sanderson E; Dudbridge F; Burgess S; Cornelis MC; Richardson TG; Borges MC; Bowden J; Hemani G; Cho Y; Spiller W; Richmond RC; Carter AR; Langdon R; Lawlor DA; Walters RG; Vimaleswaran KS; Anderson A; Sandu MR; Tilling K; Davey Smith G; Martin RM; Relton CL;
    Cancer Causes Control; 2022 May; 33(5):631-652. PubMed ID: 35274198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mendelian randomization in health research: using appropriate genetic variants and avoiding biased estimates.
    Taylor AE; Davies NM; Ware JJ; VanderWeele T; Smith GD; Munafò MR
    Econ Hum Biol; 2014 Mar; 13(100):99-106. PubMed ID: 24388127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Challenges and factors that influencing causal inference and interpretation, based on Mendelian randomization studies].
    Wang YZ; Shen HB
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Aug; 41(8):1231-1236. PubMed ID: 32867428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficient design for Mendelian randomization studies: subsample and 2-sample instrumental variable estimators.
    Pierce BL; Burgess S
    Am J Epidemiol; 2013 Oct; 178(7):1177-84. PubMed ID: 23863760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conducting a Reproducible Mendelian Randomization Analysis Using the R Analytic Statistical Environment.
    Rasooly D; Patel CJ
    Curr Protoc Hum Genet; 2019 Apr; 101(1):e82. PubMed ID: 30645041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A review of instrumental variable estimators for Mendelian randomization.
    Burgess S; Small DS; Thompson SG
    Stat Methods Med Res; 2017 Oct; 26(5):2333-2355. PubMed ID: 26282889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An introduction to instrumental variables--part 2: Mendelian randomisation.
    Bennett DA
    Neuroepidemiology; 2010; 35(4):307-10. PubMed ID: 21042034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mendelian Randomization Analysis in Observational Epidemiology.
    Lee K; Lim CY
    J Lipid Atheroscler; 2019 Sep; 8(2):67-77. PubMed ID: 32821701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interpretation and Potential Biases of Mendelian Randomization Estimates With Time-Varying Exposures.
    Labrecque JA; Swanson SA
    Am J Epidemiol; 2019 Jan; 188(1):231-238. PubMed ID: 30239571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mendelian randomization studies on atherosclerotic cardiovascular disease: evidence and limitations.
    Hu Q; Hao P; Liu Q; Dong M; Gong Y; Zhang C; Zhang Y
    Sci China Life Sci; 2019 Jun; 62(6):758-770. PubMed ID: 31104264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reporting and methodological quality of studies that use Mendelian randomisation in UK Biobank: a meta-epidemiological study.
    Gibson MJ; Spiga F; Campbell A; Khouja JN; Richmond RC; Munafò MR
    BMJ Evid Based Med; 2023 Apr; 28(2):103-110. PubMed ID: 36600446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mendelian randomization incorporating uncertainty about pleiotropy.
    Thompson JR; Minelli C; Bowden J; Del Greco FM; Gill D; Jones EM; Shapland CY; Sheehan NA
    Stat Med; 2017 Dec; 36(29):4627-4645. PubMed ID: 28850703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An integrated approach to the meta-analysis of genetic association studies using Mendelian randomization.
    Minelli C; Thompson JR; Tobin MD; Abrams KR
    Am J Epidemiol; 2004 Sep; 160(5):445-52. PubMed ID: 15321841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Re: "credible mendelian randomization studies: approaches for evaluating the instrumental variable assumptions".
    Palmer TM; Ramsahai RR; Lawlor DA; Sheehan NA; Didelez V
    Am J Epidemiol; 2012 Sep; 176(5):457-8; author reply 458. PubMed ID: 22850793
    [No Abstract]   [Full Text] [Related]  

  • 38. Mendelian Randomization With Repeated Measures of a Time-varying Exposure: An Application of Structural Mean Models.
    Shi J; Swanson SA; Kraft P; Rosner B; De Vivo I; Hernán MA
    Epidemiology; 2022 Jan; 33(1):84-94. PubMed ID: 34847085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mendelian randomization analyses in ocular disease: a powerful approach to causal inference with human genetic data.
    Li J; Li C; Huang Y; Guan P; Huang D; Yu H; Yang X; Liu L
    J Transl Med; 2022 Dec; 20(1):621. PubMed ID: 36572895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cross-fitted instrument: A blueprint for one-sample Mendelian randomization.
    Denault WRP; Bohlin J; Page CM; Burgess S; Jugessur A
    PLoS Comput Biol; 2022 Aug; 18(8):e1010268. PubMed ID: 36037248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 129.